Medicare Enrolled

Dr. Agostino Iarrobino, DO

Internal Medicine · Dedham, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
200 PROVIDENCE HWY, Dedham, MA 02026
7813267815
In practice since 2006 (19 years)
NPI: 1194891267 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Iarrobino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Iarrobino? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Iarrobino

Dr. Agostino Iarrobino is an internal medicine specialist in Dedham, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Iarrobino performed 1,202 Medicare services across 695 unique beneficiaries.

Between the years covered by Open Payments, Dr. Iarrobino received a total of $14,613 from 51 pharmaceutical and/or device companies across 841 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Iarrobino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 21% volume in MA $14,613 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,202
Medicare services
Top 21% in MA for internal medicine
695
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~63 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
248 $93 $375
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
242 $43 $225
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
191 $70 $275
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
124 $13 $60
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
91 $142 $250
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
88 $10 $55
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
81 $11 $100
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
40 $34 $79
Urine microalbumin test
A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function.
35 $6 $45
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
21 $76 $150
Quadrivalent influenza vaccine, cell culture-derived
A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods.
19 $32 $72
Pneumococcal vaccine, 23-valent
A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria.
11 $131 $300
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
11 $34 $70
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,613
Total received (2018-2024)
Avg $2,088/year across 7 years
Top 9% in MA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
841
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,613 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,646
2023
$1,789
2022
$1,665
2021
$2,299
2020
$1,843
2019
$2,569
2018
$2,803

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$469
Amgen Inc.
$290
PFIZER INC.
$240
ABBVIE INC.
$155
Antares Pharma, Inc.
$100
Novartis Pharmaceuticals Corporation
$92
Tolmar, Inc.
$60
Lilly USA, LLC
$53
Janssen Pharmaceuticals, Inc
$32
Medtronic, Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Esperion Therapeutics, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$27
Seqirus USA Inc
$25
Echosens North America, Inc.
$14
Top 3 companies account for 60.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,106
PFIZER INC.
$2,037
Amgen Inc.
$1,584
Lilly USA, LLC
$830
Novo Nordisk Inc
$780
ABBVIE INC.
$745
Antares Pharma, Inc.
$602
Esperion Therapeutics, Inc.
$542
Boehringer Ingelheim Pharmaceuticals, Inc.
$510
Takeda Pharmaceuticals U.S.A., Inc.
$446
E.R. Squibb & Sons, L.L.C.
$407
AbbVie Inc.
$384
Novartis Pharmaceuticals Corporation
$365
Merck Sharp & Dohme Corporation
$330
Celgene Corporation
$316
Janssen Pharmaceuticals, Inc
$281
Tolmar, Inc.
$257
ARBOR PHARMACEUTICALS, INC.
$200
Allergan, Inc.
$199
Egalet US Inc
$156
Allergan Inc.
$154
Endo Pharmaceuticals Inc.
$149
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$146
Supernus Pharmaceuticals, Inc.
$143
Bayer HealthCare Pharmaceuticals Inc.
$140
Bayer Healthcare Pharmaceuticals Inc.
$101
Seqirus USA Inc
$61
Biohaven Pharmaceutical Holding Company Ltd.
$58
Merck Sharp & Dohme LLC
$52
Hologic, LLC
$44
Exact Sciences Corporation
$38
BioDelivery Sciences International, Inc.
$36
Shire North American Group Inc
$34
Biohaven Pharmaceuticals, Inc.
$33
Medtronic, Inc.
$32
Acerus Pharmaceuticals Corporation
$31
Neurocrine Biosciences, Inc.
$28
Otsuka America Pharmaceutical, Inc.
$28
VBI Vaccines (Delaware) Inc.
$26
SANOFI PASTEUR INC.
$21
Alkermes, Inc.
$21
GlaxoSmithKline, LLC.
$19
Arbor Pharmaceuticals, Inc.
$19
Pharming Healthcare, Inc.
$18
AbbVie, Inc.
$15
MEDICOMP INC
$15
Zyla Life Sciences
$15
Dynavax Technologies Corporation
$15
Valeritas, Inc.
$14
Echosens North America, Inc.
$14
Genentech USA, Inc.
$13
Top 3 companies account for 39.2% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · Aimovig · Amitiza · Androgel · Aptima · Aptima HPV · BASAGLAR · BELBUCA · BELSOMRA · BREZTRI · BRILINTA · BUNAVAIL 2.1 mg 30-count box · BYSTOLIC · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Cardiac Monitor · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FibroScan · Fluad Quadrivalent · Flucelvax · Focalin · GARDASIL 9 · Heplisav-B · INGREZZA · JANUVIA · JARDIANCE · JATENZO · JYNARQUE · Kerendia · LEQVIO · LINZESS · LOKELMA · LYRICA · MINIMED 780G · MOUNJARO · NASCOBAL · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · Natesto · OTREXUP · Otezla · Otrexup · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PREMARIN · PREVNAR 20 · PreHevbrio · Prolia · QULIPTA · REYVOW · RUCONEST · Repatha · Rybelsus · SHINGRIX · SPRIX · SYMBICORT · Saxenda · TLANDO · TRINTELLIX · TRULICITY · Tresiba · Trintellix · UBRELVY · Uloric · V-GO · VERQUVO · VIBERZI · VRAYLAR · VYNDAQEL · VYVANSE · Victoza · Vivitrol 380 mg · Vyvanse · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XYOSTED · Xofluza · ZORVOLEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in MA.

Looking for an internal medicine specialist in Dedham?
Compare internal medicine physicians in the Dedham area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
5,528
Per 100K population
763.0
County median income
$126,497
Nearest hospital
WALDEN BEHAVIORAL CARE, LLC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Iarrobino is a clinical cardiology specialist, with above-average Medicare volume (top 21% in MA), with low-engagement industry engagement in the top 9% of MA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Iarrobino experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Iarrobino performed 248 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Iarrobino receive payments from pharmaceutical companies?
Yes. Dr. Iarrobino received a total of $14,613 from 51 companies across 841 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Iarrobino's costs compare to other internal medicine physicians in Dedham?
Dr. Iarrobino's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Iarrobino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →